Background: Due to the high prevalence of obesity in adults, nutrition support clinicians are encountering greater numbers of obese patients who require nutrition support during hospitalization. The purpose of this clinical guideline is to serve as a framework for the nutrition support care of adult patients with obesity. Method: A systematic review of the best available evidence to answer a series of questions regarding management of nutrition support in patients with obesity was undertaken and evaluated using concepts adopted from the Grading of Recommendations, Assessment, Development and Evaluation working group. A consensus process, that includes consideration of the strength of the evidence together with the risks and benefits to the patient, was used to develop the clinical guideline recommendations prior to multiple levels of external and internal review and approval by the A.S.P.E.N. Board of Directors. Questions:
Background
As of June 2013, the American Medical Association recognized obesity as a disease that requires medical treatment. 1, 2 Based on the National Health and Nutrition Examination Survey 2009-2010, the prevalence of obesity in the United States is 35.5% in adult men, 35 .8% in adult women, including 4.4% and 8.2% respectively with body mass index (BMI) ≥ 40 kg/m 2 . 3 Thus, nutrition support clinicians are likely to care for obese patients, particularly during hospital admissions. While nutrition support clinicians care for patients across a broad range of clinical settings, the bulk of publications available for this clinical guideline have come from hospitalized patients. Furthermore, since the clinical acuity of patients admitted to intensive care units (ICUs) is much higher than those who are not critically ill, for this guideline most recommendations have been made separately for these 2 groups of obese hospitalized patients when data were available.
Bariatric surgery is a common treatment for patients who have severe obesity, with estimates of approximately 200,000 adults treated with bariatric surgery annually in the United States. 4 Since these procedures are designed to limit the patient's nutrient intake as a strategy to promote significant and durable weight loss, patients treated with these procedures may require nutrition care. Thus, the purpose of this clinical guideline is to guide clinicians on the nutrition support care of hospitalized adult patients who have obesity. Journal of Parenteral and Enteral Nutrition 37 (6) significantly different in obese than nonobese subjects in the single large study reporting this outcome. 45 Studies with more than 300 obese patients reported more complications in obese than nonobese patients, 25, 47 as did 3 smaller studies in trauma patients. 33, 37, 48 One large study in patients admitted to the medical ICU observed no difference in complications in obese than nonobese patients. 32 These complications may impact adjunctive nutrition care and thus support our consensus that an early nutrition assessment (as for all critically ill patients) and care plan is indicated.
In the hospitalized, non-critically ill obese patient, 2 studies had more than 300 obese patients. One of these in surgical patients reported lower mortality and hospital LOS, 30 while a study of patients with myocardial infarction reported higher mortality and no difference in complications. 49 Further research is very likely to change our assessment of the outcomes associated with obesity in non-ICU patients. However, all patients should be screened for nutrition risk, and those who are at risk further assessed for nutrition status and potential development of a nutrition support care plan. 15 Clearly, more prospective, adequately powered outcomes research is needed to clarify the risks associated with varying levels of obesity in hospitalized ICU and non-ICU patients. Studies that include measures of inflammation, body composition (with a focus on lean body mass), and micronutrient status 3a. Clinical outcomes are at least equivalent in patients supported with high protein, hypocaloric feeding to those supported with high protein, eucaloric feeding. A trial of hypocaloric, high protein feeding is suggested in patients who do not have severe renal or hepatic dysfunction. Hypocaloric feeding may be started with 50%-70% of estimated energy needs or < 14 kcal/kg actual weight. High protein feeding may be started with 1.2 g/kg actual weight or 2-2.5 g/kg ideal body weight, with adjustment of goal protein intake by the results of nitrogen balance studies. 3b. Hypocaloric, low protein feedings are associated with unfavorable outcomes. Clinical vigilance for adequate protein provision is suggested in patients who do not have severe renal or hepatic dysfunction. Jeor, Swinamer, and Ireton-Jones). Frankenfield and colleagues compared multiple predictive equations with REE in patients with BMI ≥ 30 kg/m 2 and found the PSU equation to have the highest prediction accuracy of 70% ( ± 10% of REE) with the least bias or the lowest likelihood of over or underestimation. 50 In another comparison study in critically ill patients with BMI ≥ 45 kg/m 2 , accuracy of the PSU equation was highest at 76% ( ± 10% of REE) compared with other equations studied. 51 In the older critically ill obese patient ( ≥ 60 years) with BMI ≥ 30, a modified PSU appears to be more accurate than the original PSU. 50 When compared with the unmodified version, the modified PSU was found to have an accuracy rate of 70% ( ± 10% of REE) vs 58% (P = .04). 50 Further, in a case series of 7 patients (including 2 obese patients) with REE measured continuously for 7 days, the prediction error using the PSU equation was only a total of -468 ± 642 kcal (-3.7 ± 5.1%) over 1 week. 52 The PSU equations 53 In the mixed ICU and non-ICU patients, the evidence is more difficult to assess due to several important variables. The 5 studies reviewed compared multiple predictive equations (Harris-Benedict, Schofield, Mifflin-St Jeor, and others) with REE but did not include all the same predictive equations in each. All included very small samples of obese patients, 1 reported on data collected in 1991, 54 and 1 used measures from 2 different calorimeter devices. 55 Accuracy ( ± 10% of REE) varied among the equations studied with Mifflin-St Jeor (MSJ) demonstrating the highest accuracy at 70% 56 -86% 57 compared with 50% for Harris-Benedict with adjusted weight 55 and 50%, 56 62% 54 -69% 57 for Harris-Benedict using actual weight. In addition, significant bias 55 and prediction errors 54, 57 were measured that could result in undesired weight changes when applied to specific patients. The error for MSJ, however, was lower than that demonstrated with Harris-Benedict using actual weight. 56, 57 The MSJ 58 equations are as follows: Whether provision of energy requirements based on REE provides superior clinical outcomes in hospitalized patients to those with energy needs estimated by a predictive equation has not yet been evaluated in patients with obese or optimal BMI.
Question 3: Are Clinical Outcomes Improved With Hypocaloric, High Protein Diets in Hospitalized Patients With Obesity? (Tables 5-6)
Recommendation 3a. Clinical outcomes are at least equivalent in patients supported with high protein hypocaloric feeding to those supported with high protein eucaloric feeding. A trial of hypocaloric high protein feeding is suggested in patients who do not have severe renal or hepatic dysfunction (weak). Hypocaloric feeding may be started with 50%-70% of estimated energy requirements or < 14 kcal/kg actual weight. High protein feeding may be started with 1.2 g/kg actual weight or 2-2.5 g/kg ideal body weight, with adjustment of goal protein intake by the results of nitrogen balance studies. Evidence Grade: Low. 3b. Hypocaloric low protein feedings are associated with unfavorable outcomes. Clinical vigilance for adequate protein provision is suggested in patients who do not have severe renal or hepatic dysfunction (weak). Evidence Grade: Low.
Rationale. Insulin resistance, glucose intolerance, hyperlipidemia, nonalcoholic fatty liver disease, and hypoventilation syndrome are more prevalent in patients with obesity than nonobese patients. 59 As a result, the hospitalized patient with obesity is susceptible to experiencing complications associated with overfeeding. Because of these concerns, hypocaloric, high protein regimens have been designed by clinicians in an effort to minimize potential overfeeding complications while simultaneously achieving net protein anabolism.
Hypocaloric feeding is defined as providing a caloric intake less than measuredor estimated energy expenditure whereas eucaloric feeding is intended to provide a caloric intake sufficient to meet caloric needs as assessed by measured energy expenditure. Hypercaloric feeding is the provision of a caloric intake greater than caloric requirements. Hypocaloric, high protein feeding is often mistaken for permissive underfeeding. Permissive underfeeding allows for both protein and caloric deficits whereas the intent of hypocaloric, high protein diets is to provide only a calorie deficit while ensuring adequate protein intake.
Four comparative studies 59-62 and 2 case series 63,64 examined the use of hypocaloric, high protein nutrition therapy for hospitalized patients with obesity. The hypocaloric, high protein diets contained average intakes ranging from 90 g to 140 g of protein and 900 kcals to 1300 kcals daily ( Table 4 ). Significantly improved clinical outcomes, as evidenced by decreased LOS in the ICU, decreased duration of antibiotic therapy, and a trend toward decreased days of mechanical ventilation, were suggested in a single small observational study examining hypocaloric, high protein diets vs eucaloric, high protein diets for critically ill trauma patients with obesity. 61 Positive clinical outcomes were also noted for use of hypocaloric, high protein feeding in 2 observational case series of surgical patients with obesity. 63, 64 In the only randomized controlled trial that examined clinical outcomes, 59 no difference in mortality or length of hospital stay was found for hospitalized patients with obesity who received hypocaloric high protein feeding when compared with eucaloric high protein diets. All 3 comparative studies [59] [60] [61] indicated that nutrition outcomes, such as nitrogen balance and serum protein response, were similar between eucaloric and hypocaloric feeding in the presence of adequate protein intake. However, 1 large observational study indicated a worsened 60-day mortality rate when a hypocaloric diet was combined with a low protein intake (average daily caloric and protein intakes of 1000 kcals and 46 g, respectively) and given to hospitalized patients with Class II (BMI 35-39.9 kg/m 2 ) obesity. 65 The current literature, which includes a total of 163 patients supported with hypocaloric, high protein regimens, indicates that clinical outcomes for hospitalized patients with obesity are at least equivalent, if not improved, by the provision of hypocaloric feeding when adequate protein intake is given to achieve net protein anabolism. A large randomized controlled trial is warranted to ascertain whether hypocaloric, high protein nutrition therapy offers a significant therapeutic advantage over eucaloric or hypercaloric feeding with respect to clinical outcomes and avoidance of complications from overfeeding for hospitalized patients with obesity. RCT, randomized controlled trial. 
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Journal of Parenteral and Enteral Nutrition 37 (6) Data to support this recommendation are in Table 3 , where protein intake of 1.2 g/kg actual body weight (2 g/kg ideal body weight) daily was given to patients in 5 observational studies [59] [60] [61] [62] 64 with hypocaloric or eucaloric energy intake. An additional study compared protein requirements based on nitrogen balance studies separately for ICU and non-ICU patients. The ICU patients required 2-2.5 g/kg/day and the non-ICU patients 1.8-1.9 g/kg/d to approach nitrogen equilibrium with the higher requirements for those with BMI > 40 kg/ m 2 . 66 These studies included patients up to 302 kg and BMI 50.6 kg/m 2 , however most subjects were considerably below these levels. Data have not been found to establish reasonable nitrogen intake goals for patients beyond these limits. Nitrogen balance was similar at this level of protein intake whether energy intake was hypocaloric or eucaloric. These initial recommendations should be adjusted using nitrogen balance studies, with a goal of nitrogen equilibrium if possible (-4 to +4 g nitrogen/kg/d). 61 While older studies may have suggested increase in albumin or prealbumin concentration as a goal for protein intake, a more recent appreciation of the strong impact of inflammation on these measures makes them unreliable as a marker of nutrition state in most ill, hospitalized patients.
Question 4: In Obese Patients Who Have Had Malabsorptive or Restrictive Surgical Procedures for Weight Loss, What Micronutrients Should Be Evaluated? (Tables 7-8) Recommendation
Patients who have undergone sleeve gastrectomy, gastric bypass, or biliopancreatic diversion ± duodenal switch have increased risk of nutrient deficiency. In acutely ill hospitalized patients with history of these procedures, evaluation for evidence of depletion of iron, copper, zinc, selenium, thiamine, folate, and vitamins B 12 , and D is suggested as well as repletion of deficiency states. (weak). Evidence Grade: Low.
Rationale. Bariatric surgical procedures that change the capacity of the stomach facilitate weight reduction by restriction, that is, increasing satiety and reducing caloric intake.
Procedures that shorten small bowel absorptive capacity result in malabsorption of protein, energy and micronutrients to varying degrees depending on construction of the anatomy. Biliopancreatic diversion ± duodenal switch (BPD ± DS) and Roux-en-Y gastric bypass (RYGB) combine these mechanisms. Micronutrient deficiency may well be a comorbidity of severe obesity in that it appears to increase in prevalence as the degree of obesity increases in populations who have had no prior bariatric surgery. This has been documented for alpha & beta carotene, beta cryptoxanthin, lutein/zeaxanthin, lycopene, total carotenoids, iron, selenium, vitamins A, C, D, B 6, B 12 , and folic acid. [67] [68] [69] Twenty-one observational studies and 2 RCTs have investigated a variety of micronutrients. These have compared serum levels in cohorts of patients treated with different procedures and have included RYGB, sleeve gastrectomy (SG), BPD ± DS, and adjustable gastric band procedures. The duration of follow-up was generally short, with 16 studies covering 1-3 years, 69-82 3 studies 4-5 years 83-85 and 1 study 7 years. 86 The study of longest duration documented no deficiency states in patients with restrictive procedures but no malabsorptive component; however, the others have documented an increased risk of deficiency of iron, copper, zinc, selenium, thiamine, folate, and Vitamins B 12 and D as compared with preoperative populations. The proclivity of restrictive or malabsorptive procedures to exacerbate or create micronutrient deficiency states has been acknowledged by recommendations for supplementation published by the American Society for Metabolic and Bariatric Surgery and the Obesity Society. 87 For all bariatric surgery patients, a daily multiple vitamin/mineral supplement is recommended with 2 daily doses for patients with SG, RYGB, and BPD. For all patients, at least 3000 IU vitamin D daily is recommended to achieve serum 25-hydroxyvitamin D levels > 30 ng/mL; 2 mg copper daily; iron 45-60 mg from diet and supplements; and vitamin B 12 should be given as needed to maintain normal serum levels. All patients except those with BPD should take 1200-1500 mg calcium citrate daily. Evaluation of folic acid, iron and 25-hydroxyvitamin D should be done annually. Copper, zinc, selenium, and thiamine should be monitored when patients have specific findings to suggest deficiency. As with other chronic or home medications, these vitamin supplements should be continued or resumed in hospitalized patients. Copper and zinc deficiencies more common with BPD than RYGB, more prevalent over time Low BPD = biliopancreatic diversion; OBS = observational study; RCT, randomized controlled trial; RYGB = Roux-en-Y gastric bypass.
Compliance with supplement ingestion has been variable, with BPD ± DS 55%, RYGB 25%. 88 Patient follow-up with bariatric surgical programs, and hence routine surveillance of nutrition parameters, tends to diminish with time duration after the surgical procedure. The severity and prevalence of deficiency appears to increase with the interval of time after the procedure as well as with the degree of malabsorption induced by the procedure. Data evaluating micronutrient status in patients in the decades following bariatric surgical intervention are not available.
